22 Nov 2022 --- Molecular farming start-up Bright Biotech has captured a US$3.2 million investment to bring down costs for cultivated meat alternative proteins and help drive cell-based companies production to scale. The business also replaces fetal bovine serum (FBS), used in the cultivated meat sector and procured from the blood of unborn calves, reducing dependence on the dairy and meat industries.
